comparison of the melatonin effect in irritable bowel syndrome patients

Phase 2

Recruiting

• Conditions: Irritable Bowel Syndrome.; Irritable bowel syndrome

• Registration Number: IRCT20220104053626N2
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 136

Inclusion Criteria

being satisfied to participate in the study
Patients with definitive diagnosis of IBS based on ROME 4 questionnaire, with sleep disorders diagnosed based on PSQI questionnaire.
Patients with definitive diagnosis of IBS based on ROME 4 questionnaire, without sleep disorders

Exclusion Criteria

Previous history of diagnosed gastrointestinal diseases including IBD
Intestinal surgery
Depression
Receive herbal medicines

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Abdominal pain severity based on a questionnaire on a percentage scale,From zero with an increase of 25 units. Timepoint: Before and after the intervention. Method of measurement: Irritable Bowel Syndrome Symptoms Severity Questionnaire.;Quality of life based on the quality of life questionnaire for patients with irritable bowel syndrome. Timepoint: Before and after the intervention. Method of measurement: the quality of life questionnaire for patients with irritable bowel syndrome.;Intensity of bloating based on a questionnaire as a percentage scale,From zero with an increase of 25 units. Timepoint: Before and after the intervention. Method of measurement: Irritable Bowel Syndrome Symptoms Severity Questionnaire.;Stool form. Timepoint: Before and after the intervention. Method of measurement: Irritable Bowel Syndrome Symptoms Severity Questionnaire.